All In Biotech

Drug Trial Radar · NCT03922373

A Study of Benzonatate Soft Capsule in Chinese Healthy Subjects

The Single-dose and Multiple-dose Pharmacokinetic Study of Benzonatate Soft Capsule in Chinese Healthy Subjects

Last checked: Nov 20, 2026Latest source record: Apr 19, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

40

Planned (sponsor's estimate)

Start

Sep 10, 2018

Primary completion

Feb 27, 2019

Study completion Apr 30, 2019

Sponsor

Sponsor type
Industry
First posted
Apr 19, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Objective to study the pharmacokinetic, safety and efficacy of Single-dose and multiple-dose of benzonatate in Chinese healthy male and female subjects.

Conditions

  • Cough

Interventions

  • Group A: Benzonatate 100mgDrug

    Subjects in group A will be given benzonatate 100mg once after a 10-hour fast in the first day of the trail

  • Group B: Benzonatate 200mgDrug

    Subjects in group B will be given benzonatate 200mg once after a 10-hour fast in the first day of the trail, and they will be given benzonatate 200mg thrice in the second and third day of the trail, in the fourth day, they will be given benzonatate 200mg once after a 10-hour fast.

  • Group C: Benzonatate 400mgDrug

    Subjects in group C will be given benzonatate 400mg once after a 10-hour fast in the first day of the trail

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. TmaxTime frame: day 1 and day 4
  2. CmaxTime frame: day 1 and day 4
  3. t1/2Time frame: day 1 and day 4
  4. AUC0-tTime frame: day 1 and day 4
  5. AUC0-∞Time frame: day 1 and day 4
  6. CL/FTime frame: day 1 and day 4

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cspc Nbp Pharmaceutical.Co.Ltd

    Shijiazhuang, Hebei, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.